EDMONTON, Alberta, June 29 /PRNewswire-FirstCall/ -- Medical Services International Inc (OTC:MSITF) is pleased to announce that though its Research and Development department that it has developed 15 new products that will be available though an online website as well as through its distribution network. The new products have been extensively tested in SE Asia with excellent results. The new products give the Company diversity in its product line as well as establishing cash flow from other sources. As these products have been developed using natural products, they do not require regulatory approval. By establishing an online website for the purchase of these products they will be available to anyone. The website that will allow an individual to purchase the products will be available by the end of July 2006. Market studies have indicated that there will be a significant demand for the products. The products range from a disinfectant that will be used to disinfect viruses (including HIV), bacteria and Fungus. This will be particularly important related to the Avian Flu to Cough Strips that suppress coughing to a throat spray for relief of cold, mouth and throat irritations (alternative antimicrobial therapy without the side effects of antibiotics). In developing the new products, the Company used its experience in dealing with viruses and bacteria to use natural antimicrobial ingredients to treat harmful viruses, bacteria, molds, and fungi. There is a significant demand for these types of products in under developed countries as they are affordable and easy to use. It is felt that the website will show that developed countries are also looking for this type of product. The Company believes that these products will demonstrate an excellent return on its R&D costs. About VScan The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada. Medical Services International Inc trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/. NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies. DATASOURCE: Medical Services International Inc CONTACT: Robert Talbot of Medical Services International Inc, +1-780-430-6363 Web site: http://www.medicalservicesintl.com/ http://www.minerva-biotech.com/

Copyright